Pharmafile Logo

patient expectations

- PMLiVE

FDA looks to regulate digital tools

US regulator adds new components to digital health plan

- PMLiVE

Leo has its eyes on the prize

The company looks to the future as it bids to find novel ways to manage and defeat debilitating skin conditions

- PMLiVE

Novo Nordisk fends off Lilly’s GLP-1 challenge in Q1

Insulin specialist bounces back with encouraging signs from Ozempic launch

- PMLiVE

J&J pays $140m upfront for cancer-busting virus firm BeneVir

The total value of the deal could go above $1bn if the biotech’s candidates perform well

- PMLiVE

Profit: the ugly, dirty truth?

“My shareholders expect me to make the most profit. That's the ugly, dirty truth.”

Pharnext appoints COO

Amit Kohli joins the biopharma from Eurofins

- PMLiVE

Incisive Health adds to its team

Maddy Farnworth and Tom Stephens join the consultancy

- PMLiVE

Data-driven creative agency launched

Ark is based in London, UK

- PMLiVE

Nokia’s digital health unit returns to its roots

Éric Carreel plans to reacquire the business

- PMLiVE

Pfizer’s flat sales focus investor attention on M&A

But CEO Ian Reed insists that there is no need for a large-scale acquisition

- PMLiVE

Morning brief: CAR-T competition hots up, Keytruda sales soar and more

A rapid round-up of pharma, biotech and healthcare news

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links